Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across the globe for EPLive 2018

Food and Healthcare Press Releases Monday March 19, 2018 10:08
AUSTIN, Texas--19 Mar--PRNewswire/InfoQuest

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia and Latin America, as well as experts from across the United States, attended the two-day educational conference in Austin, Texas. Attendees included practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex arrhythmias—a condition in which the heart beats with an irregular or abnormal rhythm.

EPLive 2018 used live and recorded cases with expert commentary as the primary teaching tool. Cases were broadcast from some of the world's premier treatment centers, such as TCAI, Mayo Clinic, Stanford University Medical Center, Mount Sinai Hospital, UCLA Health System, the University of Pennsylvania Health System, University of Texas Southwestern Medical Center, University of Colorado Hospital, Vanderbilt Heart and Vascular Institute, Lancaster General Hospital and Massachusetts General Hospital.

The conference featured demonstrations by Dr. Andrea Natale, F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI and EPLive course director, as well as a number of TCAI physicians including course co-director Dr. Amin Al-Ahmad, Dr. Rodney Horton, Dr. Patrick Hranitzky, Dr. Robert Canby, Dr. Joseph Gallinghouse, Dr. Shane Bailey, Dr. Javier Sanchez, Dr. David Burkhardt, Dr. Jason Zagrodzky and Dr. Luigi DiBiase.

"EPLive is designed to bring the world's top cardiac electrophysiology physicians and researchers together to share the latest advances in interventional cardiac electrophysiology, as well as the tools and technology required to safely and effectively treat patients with heart rhythm disorders," Dr. Natale said. "Ultimately, this allows us to significantly improve outcomes for patients worldwide."

EPLive 2018 provided attending physicians with a better understanding of techniques used to treat atrial and ventricular arrhythmias, as well as implant complex devices and extract malfunctioning devices. Cases included procedures such as atrial fibrillation (A Fib) ablation, ventricular tachycardia (VT) ablation, epicardial and endocardial VT ablation, left atrial appendage closures, lead extraction and venoplasty.

EPLive 2018 also featured new technology, such as the Confirm Rx(TM) Insertable Cardiac Monitor (ICM) , the world's first and only smartphone-compatible monitor designed to help doctors identify even the most difficult-to-detect cardiac arrhythmias, and the CardioInsight(TM) vest , a noninvasive, 3-D mapping system worn by patients to collect chest ECG signals. Doctors then combine the signals with CT scan data to identify abnormal heart rhythms.

Physicians received a maximum of 18 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit(TM) hours at the conference.
For more information, visit EPLiveSymposium.com .
Media Contacts:
Erin Ochoa and Tina Shively
Elizabeth Christian Public Relations
+1.512.472.9599
Video - https://www.youtube.com/watch?v=dV-iU4U_1dI

Latest Press Release

Medical Devices ASEAN 2018 supports the push to position Thailand as the medical hub of Asia

Medical Devices ASEAN 2018 ("MDA 2018") – the international exhibition and academic congress on medical devices, technologies, services and general healthcare – opens today and runs until Friday, 13 July 2018 at Hall 1-2, IMPACT Exhibition...

Berlinger Group Presents Arrangements for the Future Provision of Its World-renowned Anti-doping Products

- Distribution and further development of Berlinger anti-doping products to be entrusted to a foundation; Berlinger Board of Directors appoints new Group CEO The Swiss-based Berlinger Group (which comprises Berlinger & Co. AG and Berlinger Special...

Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave

Ideal Cures, an Indian company headquartered in Mumbai, India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad, India...

A Century After Umami#s Discovery, Its Benefits Continue to Expand

Umami, known as the savory taste, was discovered more than a century ago, yet recent research continues to document the benefits of umami. Currently underway is a year-long recognition of umami's 110th anniversary since its discovery in 1908. At one...

Merck Launches Online Platform Fertility.com

- Offering the latest scientific information to healthcare professionals in the advancing field of fertility - Supporting women, men and couples who are looking for information about fertility and/or undergoing fertility treatment (Photo:...

Related Topics